Visual Quality Following Aspheric Intraocular Lens (IOL) Implantation - a Comparative Clinical Study
751
1 other identifier
interventional
42
1 country
1
Brief Summary
To evaluate visual acuity and quality of vision in participants undergoing cataract surgery with a Hoya model 751 intra-ocular lens and to compare the visual results to the common monofocal lens in use.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2012
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2012
CompletedFirst Submitted
Initial submission to the registry
February 21, 2012
CompletedFirst Posted
Study publicly available on registry
March 6, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2012
CompletedMarch 25, 2015
August 1, 2012
6 months
February 21, 2012
March 23, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Uncorrected Visual Acuity (UCVA) (ETDRS)for distance, intermediate and near
Up to 3 months
Study Arms (3)
Both Eyes
EXPERIMENTALModel 751 IOL implanted in both eyes.
Single eye
EXPERIMENTALModel 751 IOL in one eye
Control
ACTIVE COMPARATORAphakia treatment by negatively aspheric IOL implant, Hoya iSert model 251 or equivalent
Interventions
Model 751 in one eye, standard IOL in other eye
Negatively aspheric IOL in both eyes
Eligibility Criteria
You may qualify if:
- Senile cataract
- Patient identified as a candidate for cataract surgery and IOL implantation
- Willing to sign informed consent document approved by the Ethical Committee
- Willing to complete all required tests and exams per this protocol
You may not qualify if:
- Amblyopia
- History or evidence of any ocular disease that may affect visual acuity
- Previous ocular surgery, including refraction surgery
- Ocular anomalies (e.g. microphthalmos, kerataconous)
- Subjects with greater than 1.0 D of corneal astigmatism
- Subjects who experience intraoperative complications that could affect postoperative IOL centration or tilt
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sir Charles Gairdner Hospital
Nedlands, Western Australia, 6009, Australia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Graham Barrett, MD
Sir Charles Gairdner Hospital, Nedlans WA
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 21, 2012
First Posted
March 6, 2012
Study Start
February 1, 2012
Primary Completion
August 1, 2012
Study Completion
August 1, 2012
Last Updated
March 25, 2015
Record last verified: 2012-08